Alcon Inc

ALCNYSE · USD
74.11USD0.00 (+0.64%)
687

Alcon Inc (ALC) Covered Calls

Alcon Inc trades in the Medical Instruments & Supplies industry with an IV Rank of 46.03%, average versus the past year. ALC's highest covered call setup is the $77.50 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 5.24% out of the money with 4 days to expiration, a 5.31% return until expiration, and a 484.50% theoretical annualized return. Across the setups shown, annualized returns run from 73.44% to 484.50% at strikes between $75.00 and $110.00, with 4 to 213 days to expiration, as of Nov 16, 2026.

Read more

Running ALC covered calls helps you generate income from Alcon Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ALC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ALC stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ALC covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ALC covered call is worth writing.

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.

2026-11-20477.505.240.050.15391.005.31484.50-0.07+0.081,2510.10
2026-11-20475.001.850.350.85171.002.32211.89-0.48+0.337860.50
2026-12-183282.5012.030.100.75896.0012.17138.78-0.14+0.13960.65
2027-01-156087.5018.820.050.601391.0018.89114.91-0.07+0.09260.55
2026-12-183280.008.640.401.00676.009.18104.71-0.54+0.204050.60
2027-01-156085.0015.430.250.801161.0015.7795.91-0.34+0.135980.55
2027-02-199590.0022.220.050.901641.0022.2885.62-0.07+0.1040.85
2027-06-17213110.0049.380.101.203646.0049.5184.84-0.14+0.0801.10
2027-01-156082.5012.030.500.80936.0012.7177.32-0.68+0.17150.30
2027-06-17213105.0042.590.200.953156.0042.8673.44-0.27+0.0800.75

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank46.03% Moderate
  • Market cap (M$)35,528
  • 52 weeks high-15.44%
  • 52 weeks low19.84%
  • Analyst recommendationBuy
    1.88
  • Target price$82.77
    11.69% above the current stock price
  • Dividend—
  • Payout ratio16.97%
  • Earnings date2026-11-10
  • P/E54.32
  • Future P/E19.04
  • EPS (ttm)1.36
  • EPS growth next 5 years12.81%

As of Nov 17, 2026